Gene therapy for familial hypercholesterolemia

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 11, Issue 5 SUPPL. 5, 2001, Pages 40-44

  Rader, D J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atherosclerosis; Cholesterol; Gene therapy; Lipoproteins; Vectors

Indexed keywords

ANIMAL; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; METHODOLOGY; REVIEW;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II;

EID: 18544393448     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hobbs HH, Brown MS, Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1: 445-446
2. Gordon BR, Stein E, Jones P, Illingworth DR (1994) Indications for low-density liproprotein apheresis. Am J Cardiol 74: 1109-1112
3. Berkner KL (1988) Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6:616-629
4. Samulski RJ, Chang LS, Shenk T (1989) Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 63:3822-3828
5. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM (1994) Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91:4407-4411
6. Yang Y, Ertl HC, Wilson JM (1994) MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1: 433-442
7. Engelhardt JF, Ye X, Doranz B, Wilson JM (1994) Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91:6196-6200
8. Ye X, Robinson M, Batshaw M, Furth E, Smith I, Wilson JM (1996) Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J Biol Chem 271: 3639-3646
9. Tsukamoto K, Smith P, Glick JM, Rader D (1997) Liver-directed gene transfer and prolonged expression of three major human apoE isoforms in apoE-deficient Mice. J Clin Invest 100: 107-114
10. Tsukamoto K, Tangirala R, Chun SH, Puré E, Rader DJ (1999) Rapid regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein E in apoE deficient mice. Arterioscler Thromb Vase Biol 19: 2162-2170
11. Tangirala RK, Tsukamoto K, Chun SH, Usher D, Puré E, Rader DJ (1999) Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 100: 1816-1822
12. Gao GP, Yang Y, Wilson JM (1996) Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 70: 8934-8943
13. Raper SE, Haskal ZJ, Ye X, Pugh C, Furth EE, Gao GP, Wilson JM (1998) Selective gene transfer into the liver of non-human primates with El-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses. Hum Gene Ther 9:671-679
14. Batshaw ML, Wilson JM, Raper S, Yudkoff M, Robinson MB (1999) Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD). Hum Gene Ther 10: 2419-2437
15. Carmen IH (2001) A death in the laboratory: the politics of the Gelsinger aftermath. Mol Ther 3: 425-428
16. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL (1996) A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 93: 13565-13570
17. Fisher K, Choi H, Burda J, Chen S, Wilson JM (1996) Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217: 11-22
18. Haecker S, Stedman H, Balice-Gordon R, Smith D, Greelish J, Mitchell M, Wells A, Sweeney L, Wilson JM (1996) In vivo expression of full-length dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther 7: 1907-1914
19. Chen H, Mack L, Kelly R, Ontell M, Kochanek S, Clemens P (1997) Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc Natl Acad Sci USA 94: 1645-1650
20. Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S (1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18: 180-183
21. Morsy MA, Gu M, Motzel S, Zhao J, Lin J, Su Q, Allen H, Franlin L, Parks RJ, Graham FL, Kochanek S, Bett AJ, Caskey CT (1998) An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci USA 95: 7866-7871
22. Sandig V, Youil R, Bett AJ, Franlin LL, Oshima M, Maione D, Wang F, Metzker ML, Savino R, Caskey CT (2000) Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci USA 97: 1002-1007
23. Oka K, Pastore L, Kim IH, Merched A, Nomura S, Lee HJ, Merched-Sauvage M, Arden-Riley C, Lee B, Finegold M, Beaudet A, Chan L (2001) Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation 103: 1274-1281
24. Kotin RM (1994) Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 5: 793-801
25. Koeberl D, Alexander I, Halbert C, Russell D, Miller AD (1997) Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc Natl Acad Sci USA 94: 1426-1431
26. Xiao W, Berta SC, Lu MM, Moscioni AD, Tazelaar J, Wilson JM (1998) Adeno-associated virus as a vector for liver-directed gene therapy. J Virol 72: 10222-10226
27. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16: 270-276
28. Wang L, Nichols TC, Read MS, Bellinger DA, Verma IM (2000) Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol Ther 1: 154-158
29. Snyder RO, Miao C, Meuse L, Tubb J, Donahue BA, Lin HF, Stafford DW, Patel S, Thompson AR, Nichols T, Read MS, Bellinger DA, Brinkhous KM, Kay MA (1999) Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 5: 64-70
30. Chao H, Mao L, Bruce AT, Walsh CE (2000) Sustained expression of human factor VIII in mice using a parvovirus-based vector. Blood 95: 1594-1599
31. Chen SJ, Rader DJ, Tazelaar J, Kawashiri M, Gao G, Wilson JM (2000) Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Mol Ther 2: 256-261
32. Ledley F (1996) Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 6: 1129-1144
33. Zhu N, Liggitt D, Debs R (1993) Systemic gene expression after intravenous DNA delivery into adult mice. Science 261: 209-211
34. Wu G, Wilson JM, Shalaby F, Grossman M, Shafritz D, Wu C (1991) Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in nagase rats. J Biol Chem 266: 14338-14342
35. Chemin I, Moradpour D, Wieland S, Offensperger WB, Walter E, Behr JP, Blum HE (1998) Liver-directed gene transfer: a linear polyethlenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo. J Viral Hepat 5: 369-375
36. Michael S, Curiel DT (1994) Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther 1: 223-232
37. Ramani K, Hassan Q, Venkaiah B, Hasnain SE, Sarkar DP (1998) Site-specific gene delivery in vivo through engineered Sendai viral envelopes. Proc Natl Acad Sci USA 95: 11886-11890
38. Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel DT, Birnstiel ML (1992) Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 89: 6099-6103